Fertility Myths vs. Medical Facts

While conception comes easily for some couples, at least one in ten couples (5 to 6 million couples annually) experience clinical infertility. It is virtually impossible to predict in advance who will conceive quickly and who will encounter physiological obstacles. Fertility decreases sharply after age 35, and natural monthly fecundity in the early 40s drops below 5%, approaching zero by age 45. If career goals require delaying childbearing, proactive elective egg freezing in your 20s or early 30s preserves future reproductive options.

Regular 28-day cycles generally confirm that ovulation is taking place, but ovulation is only one piece of the reproductive puzzle. Even with predictable cycles, conception can be blocked by blocked fallopian tubes, silent endometriosis, uterine polyps or fibroids, poor egg quality (diminished reserve), or male factor sperm deficiencies.

A woman's reproductive potential naturally declines with age. While women under 35 have an approximate 20% chance of conceiving each cycle, that likelihood drops to ~5% by age 40, accompanied by a steep rise in miscarriage rates. By age 40, over 50% of a woman's remaining eggs are chromosomally abnormal (aneuploid). The majority of high-profile media stories celebrating pregnancies at age 44–48 involve previous egg freezing or the use of young, healthy donor eggs.

This is known as secondary infertility, and it accounts for nearly 50% of all infertility cases. Having a prior child provides no immunity against advancing maternal age, diminished ovarian reserve (AMH), new pelvic scarring from cesarean delivery or infections, developing male factor issues, or emerging ovulatory disorders.

Infertility is equally shared between partners. Scientifically:

• 40% of cases are attributed exclusively to female factors.
• 40% of cases are attributed exclusively to male factors (sperm count, motility, morphology, or DNA fragmentation).
• 10% are combined male and female factors.
• 10% are unexplained despite full workup.

A comprehensive male evaluation—including semen analysis and Sperm DNA Fragmentation Testing—must always occur at the start of fertility evaluations.

An annual OB/GYN exam is vital for preventative wellness (Pap smears, breast exams, pelvic exams), but it does not evaluate fertility. A normal Pap smear or bimanual exam cannot reveal whether your fallopian tubes are blocked (requiring an HSG), whether your ovarian egg supply is low (requiring AMH blood testing and Antral Follicle Counts), or whether your partner's sperm parameters are compromised.

Infertility is a recognized physical medical condition, not a psychological weakness. While chronic distress affects overall wellbeing, relaxing cannot unblock fallopian tubes, fix severe male factor oligospermia, or reverse chromosomal aneuploidy in eggs. Telling struggling patients to "just relax" is medically unfounded and causes unwarranted self-blame.

Body mass index (BMI) directly impacts hormone regulation. Adipose tissue converts androgens into estrogens via the enzyme aromatase. Being significantly overweight, obese (BMI > 30), or severely underweight (BMI < 18.5) disrupts the hypothalamic-pituitary-ovarian axis, leading to irregular cycles, anovulation, and poor egg and sperm quality. Learn more about Obesity and Fertility and The Infertility Diet™.

Cigarette smoke toxins (cadmium, cotinine, polycyclic aromatic hydrocarbons) accelerate follicular atresia, permanently damage ovarian reserve, and advance menopause by 1 to 4 years. In men, smoking causes severe sperm DNA fragmentation and impairs sperm motility. Extensive research by Dr. Fady Sharara demonstrates the toxicity of smoking on assisted reproduction, which is why VCRM maintains a strict smoking cessation policy for treatment safety.

This is one of the most widespread biological misunderstandings. Women are born with their entire lifetime egg supply (approx. 1–2 million at birth; 300,000–500,000 at puberty). Every month, the body naturally awakens a cohort of 15 to 30 immature follicles. In a natural cycle, only one dominant follicle matures to ovulate, and the rest naturally disintegrate and die off (atresia). Fertility medications (such as Gonal-F, Follistim, Menopur) simply provide the FSH support needed to rescue that month's cohort from dying, allowing multiple mature eggs to be retrieved. They do not borrow or deplete eggs from future cycles.

Clinical studies show that 85% to 90% of women who will conceive using Clomiphene Citrate (Clomid) do so within the first 3 to 4 ovulatory cycles. Continuing Clomid beyond 3–6 cycles provides negligible therapeutic benefit and can thin the endometrial lining or thicken cervical mucus due to its anti-estrogenic effects. If pregnancy has not occurred after 3–4 cycles, you should transition to a fertility specialist for advanced diagnostics and treatment escalation.

At VCRM, Dr. Sharara emphasizes conservative, stepwise, diagnostic-first medicine. We complete a full evaluation to find the root cause of infertility before recommending any intervention. The majority of our patients conceive using less invasive, lower-cost therapies—such as targeted ovulation induction, lifestyle optimization, or Intrauterine Insemination (IUI)—without ever requiring IVF.

Fertility clinic success rates vary dramatically. In the Washington, D.C. / Northern Virginia metropolitan area, verified CDC and SART live birth success rates range from under 20% to over 60% per transfer. Differences in physician expertise, individualized protocol design, and cleanroom air quality in the IVF Laboratory have a massive impact on your chances of bringing home a baby. Traveling a few extra miles for proven excellence is worth the investment.

Nearly 75% of patients at VCRM have some degree of insurance coverage for initial diagnostic evaluations, bloodwork, ultrasound imaging, semen analysis, or fertility medications. Furthermore, for non-covered treatments, VCRM provides transparent pricing, flexible financing options, and exclusive 100% IVF Refund Plans.